About
Antibacterial drugs
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (32)
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
1,515
By Phase
PHASE1: 3NA: 7
By Status
COMPLETED: 9ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06916156Lead Sponsor
Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants
PHASE1Completed
26 participants
Started: Apr 28, 2025 · Completed: Aug 19, 2025
NCT06527677Lead Sponsor
Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects
PHASE1Completed
41 participants
Started: Jul 19, 2024 · Completed: Jul 10, 2025
NCT06154525Lead Sponsor
Effectiveness of Bacillus Spore Probiotics in Reducing Constipation, Anorexia, and Slow Weight Gain in Children
NACompleted
201 participants
Started: Mar 10, 2024 · Completed: Sep 30, 2024
NCT06148194Lead Sponsor
Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
NACompleted
600 participants
Started: Jan 2, 2024 · Completed: Oct 23, 2024
NCT06165354Lead Sponsor
Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis
NACompleted
120 participants
Started: Dec 1, 2023 · Completed: Jun 30, 2025
Locations (1)
Headquarters
Labège, France
Map
Loading map...